Zymeworks (ZYME) Tax Rate (2021 - 2026)

Zymeworks (ZYME) posted Tax Rate of 4.73% for Q1 2026, up 626.15% sequentially from 0.65% in Q4 2025, and up 697.0% YoY from 0.59% in Q1 2025.

Zymeworks (ZYME) Tax Rate (2021 - 2026) Analysis & Trends

Zymeworks has reported Tax Rate for 6 years, with the latest figure at 4.73% in Q1 2026.

Quarterly Tax Rate rose 697.0% year-over-year to 4.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.26% (up 733.0% YoY) and the FY2025 annual result came in at 1.73%, up 349.0% from the prior year.
Tax Rate rose to 4.73% in Q1 2026 per ZYME's latest filing, from 0.65% in the prior quarter.
Over five years, Tax Rate peaked at 24.59% in Q4 2023 and troughed at 32.12% in Q4 2024.
A 5-year average of 1.85% and a median of 0.24% in 2024 frame the typical range for Tax Rate.
The sharpest annual moves came in 2024 and 2025: Tax Rate plunged 5671 bps in 2024, then jumped 3277 bps in 2025.
Over 5 years, Tax Rate stood at 3.43% in 2022, then surged by 616 bps to 24.59% in 2023, then plunged by 231 bps to 32.12% in 2024, then soared by 102 bps to 0.65% in 2025, then soared by 626 bps to 4.73% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 4.73%, 0.65%, and 7.31% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Zymeworks	1.79 Bn	1.52 Bn	-	0.60%

Download Data